Streetbeat News

EVTZF

Evertz Technologies Limited

Industry

Electromedical and Electrotherapeutic Apparatus Manufacturing

Open

8.74

Mkt cap

664M

Volume

100

High

8.74

P/E Ratio

16.49

52-wk high

11.87

Low

8.74

Div yield

0.05

52-wk low

8.61

Evertz Technologies Limited (EVTZF) held its Q2 2025 earnings call, discussing financial results and business developments. Key participants included Brian Campbell, EVP of Business Development, and Doug Moore, CFO. Analysts from BMO Capital Markets and Canaccord Genuity participated in the call.

Portfolio Pulse from

December 11, 2024 | 12:00 am

Evertz Technologies reported strong second quarter results with a 12.2% increase in revenue to $125.3 million and a 69.7% rise in earnings from operations. The company also increased its regular quarterly dividend to $0.20 per share.

Portfolio Pulse from

December 10, 2024 | 9:15 pm

Evertz Technologies Limited is set to release its second quarter 2024 financial results on December 10, 2024. A conference call with financial analysts will follow the release.

Portfolio Pulse from

November 29, 2024 | 9:30 pm

Canaccord Genuity analyst Robert Young has maintained a Buy rating on Evertz Technologies (EVTZF) and increased the price target from $19 to $19.5.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 5:17 pm

Canaccord Genuity analyst Robert Young maintains a Buy rating on Evertz Technologies (OTC:EVTZF) and raises the price target from C$15 to C$19.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 5:09 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.